Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.

Rivaroxaban fails to take on covert brain infarcts

22 Oct 2020

Use of rivaroxaban, with or without aspirin, falls short of reducing the number of incident covert infarcts compared with aspirin alone in patients with stable coronary and peripheral vascular disease, according to a study.

The current analysis included a subgroup of 1,445 participants with stable vascular disease from the COMPASS trial, which evaluated the effect of rivaroxaban with or without aspirin compared with aspirin monotherapy on stroke, myocardial infarction, and vascular death outcomes. All participants had completed baseline and follow-up magnetic resonance imaging (MRI) with a mean interval of 2.0 years. Whole-brain T1, T2 fluid-attenuated inversion recovery, T2 sequences were centrally interpreted by blinded, trained readers. Cognition and functional status were also assessed.

At baseline, 493 (34.1 percent) participants had infarcts. Incident covert infarcts occurred in 55 (3.8 percent) participants over the follow-up. In the overall trial, rivaroxaban plus aspirin vs aspirin monotherapy reduced the risk of ischaemic stroke by 49 percent (0.7 percent vs 1.4 percent; hazard ratio, 0.51, 95 percent confidence interval [CI], 0.38–0.68).

In the MRI substudy, the combination of rivaroxaban plus aspirin did not significantly differ with aspirin alone in terms of the incidence of covert infarcts (2.7 percent vs 3.5 percent; odds ratio [OR], 0.77, 95 percent CI, 0.37–1.60; p=0.48) and the composite of covert infarcts or ischaemic stroke (2.9 percent vs 5.3 percent; OR, 0.53, 95 percent CI, 0.27–1.03; p=0.061).

Overall, 6.6 percent of participants developed microbleeds and 65.7 percent had an increase in white matter hyperintensities volume, with no effect of treatment for either endpoint. Results for cognitive tests showed no material change.

In light of the findings, the researchers underscored that a sequential hierarchical analysis plan with a combined outcome of covert and clinical infarcts, followed by each component separately, might be optimal.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.
5 days ago
Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.